Bluestar Adisseo Company (SHA:600299)

China · Delayed Price · Currency is CNY

8.57

+0.25 (3.00%)

Sep 4, 2026, 3:00 PM CST

Market Cap	26.39B +0.8%
Revenue (ttm)	18.43B +9.8%
Net Income	1.32B -1.3%
EPS	0.45 -9.6%
Shares Out	3.08B
PE Ratio	19.02
Forward PE	15.72
Dividend	0.15 (1.81%)
Ex-Dividend Date	Jul 10, 2026

Volume	54,693,501
Open	8.32
Previous Close	8.32
Day's Range	8.32 - 8.77
52-Week Range	7.62 - 16.48
Beta	0.27
Analysts	Buy
Price Target	12.85 (+49.94%)
Earnings Date	Aug 31, 2026

About Bluestar Adisseo Company

Bluestar Adisseo Company, together with its subsidiaries, engages in the research, development, production, and sale of poultry, ruminant, swine, and aquaculture nutrition additives. The company also offers mycotoxin management and palatability comprising, Unike Plus, Unike, Oxy-Nil, Mold-Nil, Salmo-Nil, Toxy-Nil, Krave AP, Optisweet, Gusti Plus, Maxarome, Delistart, Pepsea, Nutri-Bind Aqua, and Oxy-Nil Aqua Zero; enzymes and emulsifiers, including Rhodimet AT88 and Rhodimet; antioxidants and health by nutrition products, comprising Rhodimet AT... [Read more]

Industry Specialty Chemicals

Sector Materials

Founded 1939

Employees 3,295

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 600299

Full Company Profile

Financial Performance

In 2025, Bluestar Adisseo Company's revenue was 17.23 billion, an increase of 10.92% compared to the previous year's 15.53 billion. Earnings were 1.15 billion, a decrease of -4.13%.

Financial Statements

Analyst Summary

According to 3 analysts, the average rating for 600299 stock is "Buy." The 12-month stock price target is ¥12.85, which is an increase of 49.94% from the latest price.

Price Target

¥12.85

(49.94% upside)

Analyst Consensus: Buy

Stock Forecasts